WeRide's HK IPO: CICC & Morgan Stanley Underwrite, No Cornerstone Investors, 27.5% Premium Over US Shares, H1 Robotaxi Revenue Soars 360%+

Deep News
2025/10/31

**IPO Details** WeRide Inc. (WRD) has filed for a Hong Kong IPO with CICC and Morgan Stanley as joint sponsors. The offering features no cornerstone investors and adopts Mechanism A allocation.

**Financial Performance** From 2022 to H1 2025, WeRide reported revenues of RMB528M, RMB402M, RMB361M, and RMB200M respectively, with a -17.3% CAGR (2022–2024). However, H1 2025 revenue rebounded with 32.8% YoY growth, driven by Robotaxi sales surging 364.4% (46 units sold vs. 18 in H1 2024). Robotaxi now contributes 31.1% of total revenue, up from 13.2% in 2024.

Gross margins fluctuated between 44.1% (2022) and 30.6% (H1 2025), while net margins remained deeply negative (-246.1% to -696.9%). As of June 30, 2025, cash reserves stood at RMB3.836B, sufficient to fund expansion.

**Valuation & Peer Comparison** WeRide’s proposed HK market cap is HKD35.93B (PS 166.35x), a 27.5% premium to its US closing price of $10.60 (HKD82.34 after forex conversion). Peer Pony.ai trades at PS 279.65x in the US.

**Key Differentiators** - WeRide operates 1,500+ autonomous vehicles across 30+ cities in 11 countries, holding licenses in 7 jurisdictions. - Diversified product mix (Robotaxi, Robobus, Robovan, Robosweeper) vs. Pony.ai’s focus on Robotaxi/Robotruck.

**IPO Structure** - No cornerstone investors. - Mechanism A: 5% public allocation initially, scaling to 10%–20% based on oversubscription (currently 20.1x). - Total offering size: ~HKD3.089B (8.6% dilution), with 5.07% allocated to listing expenses.

**Risks** - High valuation premium over US shares. - Intense competition in autonomous driving R&D, delaying profitability. - Concurrent IPOs (Pony.ai, Joyson Electronics, etc.) may divert investor interest.

**Market Sentiment** Despite weak US performance (-27% since 2024 Nasdaq debut), WeRide’s Robotaxi growth and cash reserves could attract speculative interest. However, the pricing disparity with US shares limits upside potential.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10